- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 06-12-2025: Press Release
06-12-2025 | 10:17 am
06-12-2025 | 10:17 am
Biocon will fully integrate Biocon Biologics, acquiring remaining stakes via share swap and USD 400 million cash. Valued at USD 5.5 billion, this unifies operations, strengthening global biopharma leadership in diabetes, oncology, and immunology. Biocon plans to raise up to 4,500 Cr via QIP for the cash component.
No comments yet. Be the first to comment!